Average Co-Inventor Count = 1.52
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Santaris Pharma A/s (7 from 44 patents)
2. Enzon Pharmaceuticals, Inc. (5 from 52 patents)
3. Hoffmann-la Roche Inc. (2 from 4,945 patents)
4. Roche Innovation Center Copenhagen A/s (1 from 46 patents)
10 patents:
1. 12421552 - MicroRNA-134 biomarker
2. 12203071 - Oligonucleotide agonists targeting progranulin
3. 12104153 - Antisense oligonucleotide for targeting progranulin
4. 8492357 - Micro-RNA mediated modulation of colony stimulating factors
5. 8450290 - Methods for treating androgen receptor dependent disorders including cancers
6. 8440809 - RNA antagonists targeting Hsp27
7. 8039446 - Compounds for the modulation of beta-catenin expression
8. 7989429 - LNA antagonists targeting the androgen receptor
9. 7915401 - Compounds for the modulation of beta-catenin expression
10. 7737125 - LNA antagonists targeting the androgen receptor